Citadel Advisors »

Lipocine shares owned by Citadel Advisors

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $41k 14k 2.86

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Lipocine

Vanguard Group
BlackRock
Geode Capital Management
Susquehanna International
Renaissance Technologies
State Street Corporation
Citadel Advisors
Northern Trust
Dimensional Fund Advisors
Barclays
Advisor Group Holdings
UBS Group
Tower Research Capital
Morgan Stanley
Caldwell Sutter Capital

View all funds holding Lipocine